Novartis Investigative Site

Hull HU3 2RW

0 studies enrolling now · 8 studies all time

What they study most

Chronic Plaque Type Psoriasis, Diabetes Mellitus, Diabetes Type 1, Diabetic Macular Edema, Heart Failure With Preserved Ejection Fraction, Polymyalgia Rheumatica, Primary Biliary Cholangitis, Psoriatic Arthritis

Studies at this site

• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) — Completed
• Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema — Completed
• Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis — Completed
• A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
• 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis — Completed
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed
• ACZ885 in Type 1 Diabetes Mellitus — Withdrawn before enrolling